HDAC6 Antibody | Affinity Biosciences

Cites

1/2

HDAC6 Antibody - FIGURE 6 HDAC6 inhibition restored HTRA1 expression in iAs-exposed Caco-2 cells.

HDAC6 Antibody - Effect of emodin treatment on HDAC6 activity.

Product:	HDAC6 Antibody
Catalog:	AF6485
Description:	Rabbit polyclonal antibody to HDAC6
Application:	WB IHC IF/ICC
Reactivity:	Human, Mouse
Mol.Wt.:	131kDa; 131kD(Calculated).
Uniprot:	Q9UBN7
RRID:	AB_2835165

View similar products>>

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific.

Size	Price	Inventory
100ul	$280	In stock
200ul	$350	In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Related Downloads

MSDS

Data Sheet

COA

Protocols

WB Handbook

IHC Protocol

IF/ICC Protocol

Product Info

Source:

Rabbit

Application:

WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:

Human,Mouse

Clonality:

Polyclonal

Specificity:

HDAC6 Antibody detects endogenous levels of total HDAC6.

RRID:

AB_2835165
Cite Format: Affinity Biosciences Cat# AF6485, RRID:AB_2835165.

Conjugate:

Unconjugated.

Purification:

The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).

Storage:

Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.

Alias:

Fold/Unfold

CPBHM; FLJ16239; HD 6; HD6; HDAC 6; HDAC6; HDAC6_HUMAN; Histone deacetylase 6 (HD6); Histone deacetylase 6; JM 21; JM21; KIAA0901; OTTHUMP00000032398; OTTHUMP00000197663; PPP1R90; Protein phosphatase 1 regulatory subunit 90;

Immunogens

Immunogen:

Uniprot:

Q9UBN7(HDAC6_HUMAN) >>Visit HPA database.

Gene(ID):

HDAC6(10013)

Description:

Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA.

Sequence:

Q9UBN7 HDAC6_HUMAN:
Protein BLAST With
NCBI/
ExPASy/
Uniprot

MTSTGQDSTTTRQRRSRQNPQSPPQDSSVTSKRNIKKGAVPRSIPNLAEVKKKGKMKKLGQAMEEDLIVGLQGMDLNLEAEALAGTGLVLDEQLNEFHCLWDDSFPEGPERLHAIKEQLIQEGLLDRCVSFQARFAEKEELMLVHSLEYIDLMETTQYMNEGELRVLADTYDSVYLHPNSYSCACLASGSVLRLVDAVLGAEIRNGMAIIRPPGHHAQHSLMDGYCMFNHVAVAARYAQQKHRIRRVLIVDWDVHHGQGTQFTFDQDPSVLYFSIHRYEQGRFWPHLKASNWSTTGFGQGQGYTINVPWNQVGMRDADYIAAFLHVLLPVALEFQPQLVLVAAGFDALQGDPKGEMAATPAGFAQLTHLLMGLAGGKLILSLEGGYNLRALAEGVSASLHTLLGDPCPMLESPGAPCRSAQASVSCALEALEPFWEVLVRSTETVERDNMEEDNVEESEEEGPWEPPVLPILTWPVLQSRTGLVYDQNMMNHCNLWDSHHPEVPQRILRIMCRLEELGLAGRCLTLTPRPATEAELLTCHSAEYVGHLRATEKMKTRELHRESSNFDSIYICPSTFACAQLATGAACRLVEAVLSGEVLNGAAVVRPPGHHAEQDAACGFCFFNSVAVAARHAQTISGHALRILIVDWDVHHGNGTQHMFEDDPSVLYVSLHRYDHGTFFPMGDEGASSQIGRAAGTGFTVNVAWNGPRMGDADYLAAWHRLVLPIAYEFNPELVLVSAGFDAARGDPLGGCQVSPEGYAHLTHLLMGLASGRIILILEGGYNLTSISESMAACTRSLLGDPPPLLTLPRPPLSGALASITETIQVHRRYWRSLRVMKVEDREGPSSSKLVTKKAPQPAKPRLAERMTTREKKVLEAGMGKVTSASFGEESTPGQTNSETAVVALTQDQPSEAATGGATLAQTISEAAIGGAMLGQTTSEEAVGGATPDQTTSEETVGGAILDQTTSEDAVGGATLGQTTSEEAVGGATLAQTTSEAAMEGATLDQTTSEEAPGGTELIQTPLASSTDHQTPPTSPVQGTTPQISPSTLIGSLRTLELGSESQGASESQAPGEENLLGEAAGGQDMADSMLMQGSRGLTDQAIFYAVTPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPHPH

PTMs - Q9UBN7 As Substrate

Q9UBN7

Site	PTM Type	Enzyme	Source
S16	Phosphorylation		Uniprot
S22	Phosphorylation	P49841 (GSK3B)	Uniprot
S28	Phosphorylation		Uniprot
T30	Phosphorylation		Uniprot
K32	Ubiquitination		Uniprot
K36	Acetylation		Uniprot
K37	Acetylation		Uniprot
S43	Phosphorylation		Uniprot
K51	Ubiquitination		Uniprot
K116	Ubiquitination		Uniprot
S412	Phosphorylation		Uniprot
S458	Phosphorylation	P68400 (CSNK2A1)	Uniprot
Y570	Phosphorylation	P00533 (EGFR)	Uniprot
S846	Phosphorylation		Uniprot
S847	Phosphorylation		Uniprot
K849	Acetylation		Uniprot
K849	Ubiquitination		Uniprot
K853	Acetylation		Uniprot
K854	Acetylation		Uniprot
K854	Ubiquitination		Uniprot
K860	Ubiquitination		Uniprot
T868	Phosphorylation		Uniprot
K873	Acetylation		Uniprot
K881	Acetylation		Uniprot
T923	Phosphorylation		Uniprot
S925	Phosphorylation		Uniprot
T993	Phosphorylation		Uniprot
S995	Phosphorylation		Uniprot
T1003	Phosphorylation		Uniprot
T1016	Phosphorylation		Uniprot
T1021	Phosphorylation		Uniprot
T1027	Phosphorylation		Uniprot
T1031	Phosphorylation	P27361 (MAPK3) , P28482 (MAPK1)	Uniprot
T1034	Phosphorylation		Uniprot
S1035	Phosphorylation	P27361 (MAPK3)	Uniprot
T1040	Phosphorylation		Uniprot
T1041	Phosphorylation		Uniprot
T1048	Phosphorylation		Uniprot
T1055	Phosphorylation		Uniprot
S1062	Phosphorylation		Uniprot
K1206	Ubiquitination		Uniprot

Research Backgrounds

Q9UBN7_HDAC6_HUMAN

Function:

Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. In addition to histones, deacetylates other proteins: plays a central role in microtubule-dependent cell motility by mediating deacetylation of tubulin. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. In addition to its protein deacetylase activity, plays a key role in the degradation of misfolded proteins: when misfolded proteins are too abundant to be degraded by the chaperone refolding system and the ubiquitin-proteasome, mediates the transport of misfolded proteins to a cytoplasmic juxtanuclear structure called aggresome. Probably acts as an adapter that recognizes polyubiquitinated misfolded proteins and target them to the aggresome, facilitating their clearance by autophagy.

PTMs:

Phosphorylated by AURKA.

Ubiquitinated. Its polyubiquitination however does not lead to its degradation.

Sumoylated in vitro.

Subcellular Location:

Cytoplasm. Cytoplasm>Cytoskeleton. Nucleus. Perikaryon. Cell projection>Dendrite. Cell projection>Axon.
Note: It is mainly cytoplasmic, where it is associated with microtubules.

Subunit Structure:

Interacts with SIRT2 (via both phosphorylated, unphosphorylated, active or inactive forms); the interaction is necessary for the complex to interact with alpha-tubulin. Under proteasome impairment conditions, interacts with UBD via its histone deacetylase 1 and UBP-type zinc-finger regions. Interacts with BBIP10, CBFA2T3, CYLD, DDIT3/CHOP, ZMYND15, F-actin and HDAC11. Interacts with RIPOR2; this interaction occurs during early myogenic differentiation and prevents HDAC6 to deacetylate tubulin. Interacts with DYSF; this interaction occurs during early myogenic differentiation. Interacts with TPPP; inhibiting the tubulin deacetylase activity of HDAC6. Interacts with DYNLL1.

Family&Domains:

Belongs to the histone deacetylase family. HD type 2 subfamily.

Research Fields

· Human Diseases > Substance dependence > Alcoholism.

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Cancers: Overview > Viral carcinogenesis.

References

1). Enhanced autophagic clearance of amyloid-β via HDAC6-mediated V-ATPase assembly and lysosomal acidification protects against Alzheimer's disease in vitro and in vivo. Neural regeneration research, 2024 (PubMed: 38993141) [IF=5.9]

2). Inorganic arsenic exposure promotes malignant progression by HDAC6-mediated down-regulation of HTRA1. Journal of Applied Toxicology, 2023 (PubMed: 36861143) [IF=2.7]

Application: WB Species: Human Sample: Caco-2 cells

FIGURE 6 HDAC6 inhibition restored HTRA1 expression in iAs-exposed Caco-2 cells. (A) RT-qPCR result showed the transcript level of HTRA1 in cells from the Ctrl and iAs groups treated with WT-161 (5 μM); DMSO was used as control. (B) The protein levels of HDAC6 and HTRA1 in response to WT-161 treatment were determined by Western blot analysis. (C) Apoptosis of cells treated with panobinostat (100 nM), WT-161 (5 μM), and mocetinostat (1 μM) for 48 h was examined by cytotoxicity assay. The sensitivity of the treatment of WT-161 (5 μM), 5-FU (6 μM) or the combination of these drugs for 48 h was analyzed by (D) cytotoxicity assay and (E) DNA fragmentation ELISA. Data were representatives of at least three independent experiments, shown as mean ± SD. The Significance threshold for one-way ANOVA:

3). Emodin inhibits HDAC6 mediated NLRP3 signaling and relieves chronic inflammatory pain in mice. Experimental and therapeutic medicine, 2024 (PubMed: 38144917) [IF=2.4]

Application: WB Species: Mouse Sample:

Effect of emodin treatment on HDAC6 activity. (A) The modeled 3D structure of HDAC6 docked with emodin. (B) An enlarged view of the binding site is displayed in the inset box. (C) The interaction bonds of HDAC6 with emodin. The HDAC6 protein is shown in cyan, emodin is colored green, the interacting residues as red, bonds are shown as yellow dotted lines and bond lengths are depicted as numbers. (D) Representative immunofluorescence staining images and (E) quantitative intensity analysis of HDAC6 of each group. Scale bar, 20 µm. Representative (F) western blots and (G) quantitation of HDAC6 expression levels. Data are presented as the mean ± SD (n=5). *P

Restrictive clause

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.

HDAC6 Antibody - #AF6485